Rizzo, Manfredi <br/><br/>
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.  [electronic resource] 

 -  Diabetes, obesity & metabolism  05 2017 
 - 613-614 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12883  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzo(a)pyrene<br/>Bronchi<br/>DNA<br/>Diabetes Mellitus, Type 1<br/>Glucagon-Like Peptide-1 Receptor<br/>Humans<br/>Hypoglycemic Agents